AstraZeneca

  • Bevespi 2019 report

    Bevespi 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Brilinta 2019 report

    Brilinta 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Bydureon 2019 report

    Bydureon 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Calquence 2019 report

    Calquence 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Daliresp 2019 report

    Daliresp 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Farxiga 2019 report

    Farxiga 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Fasenra 2019 report

    Fasenra 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Imfinzi 2019 report

    Imfinzi 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Lokelma 2019 report

    Lokelma 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Lynparza 2019 report

    Lynparza 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 31 Pages The 5 Key Questions Addressed by this Report:...

  • Movantik 2019 report

    Movantik 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Symbicort 2019 report

    Symbicort 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 24 Pages The 5 Key Questions Addressed by this Report:...